OPEN LABEL

Clinical trials for OPEN LABEL explained in plain language.

Never miss a new study

Get alerted when new OPEN LABEL trials appear

Sign up with your email to follow new studies for OPEN LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

New drug takes aim at Hard-to-Treat sarcoma

Disease control Recruiting now

This early-stage trial is testing a new drug called REC-617 in 15 people with a rare type of sarcoma (leiomyosarcoma) that has spread or cannot be removed and has not responded to prior treatments. The drug targets a protein (CDK7) that helps cancer cells grow. The main goal is t…

Matched conditions: OPEN LABEL

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

OPEN LABEL

Get alerted when new OPEN LABEL trials appear

New drug takes aim at Hard-to-Treat sarcoma